The Methodist Hospital Research Institute

This study tested a mix of chemotherapy (docetaxel), an immunotherapy drug (pembrolizumab), and a gene therapy (IL-12) in 8 women with a tough-to-treat type of breast cancer that had stopped responding to standard treatment. The goal was to see if this combination could shrink or…

This early-phase study tested a combination of an immunotherapy drug (atezolizumab) and a gene therapy (IL-12) in 13 people with advanced non-small cell lung cancer that had worsened after initial immunotherapy. The goal was to see if the combination was safe and could help contr…

This study aimed to see if a specific knee exercise program could reduce pain and improve function in people with anterior knee pain. It compared the program to standard physical therapy. Only 6 people enrolled before the study was stopped early, so results are very limited.

This study aimed to check the safety of a rabies immune globulin product (HyperRAB®) in children up to 17 years old who received it after an animal bite. Researchers planned to track side effects for up to 30 days. The study was stopped early, so only limited safety information w…